AUS: (617) 38560661 | US: (855) 950-4567 | E-mail: [email protected]

Latest Research

The aim of the recent study, published January 2018, was to assess the efficacy of Urox, containing concentrated extracts of Cratevox, (Crataeva nurvala), Equisetum arvense and Lindera aggregata, in reducing symptoms of overactive bladder, including urinary urgency, day frequency, nocturia and urge urinary incontinence, as well stress urinary incontinence.

Latest Research

The aim of the recent study, published January 2018, was to assess the efficacy of Urox, containing concentrated extracts of Cratevox, (Crataeva nurvala), Equisetum arvense and Lindera aggregata, in reducing symptoms of overactive bladder, including urinary urgency, day frequency, nocturia and urge urinary incontinence, as well stress urinary incontinence.

The study results help to confirm the results of previous published and unpublished animal and human studies and demonstrate the effectiveness of Urox in improving bladder control, reducing diaper usage and improving quality of life in humans.

Results include:

  • Statistically significant reduction in urinary frequency in the Urox group compared to the placebo group.
  • Statistically significant improvement in nocturia in the Urox group compared to the placebo group
  • Statistically significant reduction in urinary urgency, in the Urox group compared to the placebo group.
  • Statistically significant reduction in stress urinary incontinence, in the Urox group compared to the placebo group.
  • Statistically significant reduction in urge urinary incontinence, in the Urox group compared to the placebo group.
  • Statistically significant reduction in diaper usage, in the Urox group compared to the placebo group.
  • Statistically significant Quality of Life (QOL) improvements using validated questionnaires found with the Urox group but not in the placebo group include:
    • Total QOL scores
    • Bothersome
    • Difficulty in coping
    • Concern/worry
    • Difficulty sleeping
    • Social interaction
  • No  significant side effects were observed resulting in withdrawal from the study

Bladder Control Background

Storage lower urinary tract (LUTS) include overactive bladder (OAB) symptoms of increased day frequency...
Learn More

Clinical Trials

Research has been the foundation of the 20-year evolution of Urox and Seipel Group...
Learn More

Conclusions

This study demonstrated significant efficacy and tolerability of the phytomedicine formula, Urox, in the treatment of UI and symptoms of OAB....
Learn More

Patents

This study demonstrated significant efficacy and tolerability of the phytomedicine formula, Urox, in the treatment of UI and symptoms of OAB....
Learn More

Contact Us For More Information

Please contact us for more information about our innovative formulations.

1
Your Name
Your Phone
Previous
Next